DiJoseph, J., K. Khandke, M. Dougher, D. Evans, D. Armellino, P. Hamann, and N. Damle. “CMC-544 (inotuzumab ozogamicin): A CD22-Targeted Immunoconjugate of Calicheamicin”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 2, no. 5, June 2009, doi:10.4081/hmr.v2i5.735.